Graphic plot analysis for estimating binding potential of translocator protein (TSPO) in positron emission tomography studies with [18F]FEDAA1106

NeuroImage

Volumn 69, Issue , 2013, Pages 78-86

  Ikoma, Yoko ^a   Takano, Akihiro ^a   Varrone, Andrea ^a   Halldin, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Binding potential; Graphical analysis; Positron emission tomography; Translocator protein (TSPO)

Indexed keywords

BENZODIAZEPINE RECEPTOR; N (5 FLUORO 2 PHENOXYPHENYL) N (2 FLUOROETHYL 5 METHOXYBENZYL)ACETAMIDE F 18; TRACER; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANALYTICAL ERROR; ARTICLE; BINDING AFFINITY; BOLUS INJECTION; COMPUTER SIMULATION; GRAPHICAL ANALYSIS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RELIABILITY; STATISTICAL ANALYSIS;

ADULT; COMPUTER SIMULATION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, GABA; YOUNG ADULT;

EID: 84872315267     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.12.009     Document Type: Article

References (57)

1. Alpert N.M., Reihac A., Chio T.C., Selesnick I. Optimization of dynamic measurement of receptor kinetics by wavelet denoising. Neuroimage 2006, 30:444-451.
2. Anderson A.N., Pavese N., Edison P., Tai Y.F., Hammers A., Gerhard A., Brooks D.J., Turkheimer F.E. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. Neuroimage 2007, 36:28-37.
3. Anholt R.R., De Souza E.B., Oster-Granite M.L., Snyder S.H. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 1985, 233:517-526.
4. Anholt R.R., Pedersen P.L., De Souza E.B., Snyder S.H. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 1986, 261:576-583.
5. Antkiewicz-Michaluk L., Guidotti A., Krueger K.E. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Mol. Pharmacol. 1988, 34:272-278.
6. 3H]PK11195 binding to activated microglia. J. Neurocytol. 1997, 26:77-82.
7. Banati R.B., Newcombe J., Gunn R.N., Cagnin A., Turkheimer F., Heppner F., Price G., Wegner F., Giovannoni G., Miller D.H., Perkin G.D., Smith T., Hewson A.K., Bydder G., Kreutzberg G.W., Jones T., Cuzner M.L., Myers R. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000, 123:2321-2337.
8. 3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 1983, 41:1744-1750.
9. Benavides J., Fage D., Carter C., Scatton B. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 1987, 421:167-172.
10. Bourdiol F., Toulmond S., Serrano A., Benavides J., Scatton B. Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide. Brain Res. 1991, 543:194-200.
11. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
12. Chen M.K., Baidoo K., Verina T., Guilarte T.R. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 2004, 127:1379-1392.
13. 11C]FLB 457. Neuroimage 2002, 17:47-60.
14. 11C]WAY 100635. Neuroimage 2006, 32:1690-1708.
15. 11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis. Nucl. Med. Biol. 2010, 37:9-15.
16. Dubois A., Benavides J., Peny B., Duverger D., Fage D., Gotti B., MacKenzie E.T., Scatton B. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res. 1988, 445:77-90.
17. 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. J. Nucl. Med. 2006, 47:43-50.
18. Guilarte T.R., Kuhlmann A.C., O'Callaghan J.P., Miceli R.C. Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. Neurotoxicology 1995, 16:441-450.
19. Gulyás B., Makkai B., Kása P., Gulya K., Bakota L., Várszegi S., Beliczai Z., Andersson J., Csiba L., Thiele A., Dyrks T., Suhara T., Suzuki K., Higuchi M., Halldin C. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Neurochem. Int. 2009, 54:28-36.
20. Gulyás B., Makkai B., Nagy K., Vas Á., Kása P., Andersson J., Suhara T., Suzuki K., Higuchi M., Beliczai Z., Gulya K., Csiba L., Halldin C. In vitro evidence for competitive TSPO binding of the imaging biomarker candidates vinpocetine and two iodinated DAA1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices. Curr. Radiopharm. 2009, 2:42-48.
21. Huang S.C., Barrio J.R., Phelps M.E. Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J. Cereb. Blood Flow Metab. 1986, 6:515-521.
22. 11C]DAA1106. J. Cereb. Blood Flow Metab. 2007, 27:173-184.
23. Ito H., Yokoi T., Ikoma Y., Shidahara M., Seki C., Naganawa M., Takahashi H., Takano H., Kimura Y., Ichise M., Suhara T. A new graphic plot analysis for determination of neuroreceptor binding in positron emission tomography studies. Neuroimage 2010, 49:578-586.
24. Kreisl, W.C., Jenko, K.J., Hines, C.S., Hyoung, Lyoo C., Corona, W., Morse, C.L., Zoghbi, S.S., Hyde, T., Kleinman, J.E., Pike, V.W., McMahon, F.J., Innis, R.B., the Biomarkers Consortium PET Radioligand Project Team, in press. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J. Cereb. Blood Flow Metab. (Sep 12. Epub ahead of print).
25. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
26. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments. J. Cereb. Blood Flow Metab. 1994, 14:439-452.
27. Le Fur G., Perrier M.L., Vaucher N., Imbault F., Flamier A., Benavides J., Uzan A., Renault C., Dubroeucq M.C., Guérémy C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci. 1983, 32:1839-1847.
28. Lin J.W., Laine A.F., Bergmann S.R. Improving PET-based physiological quantification through methods of wavelet denoising. IEEE Trans. Biomed. Eng. 2001, 48:202-212.
29. 11Cmethyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
30. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
31. Logan J., Fowler J.S., Volkow N.D., Ding Y.S., Wang G.J., Alexoff D.L. A strategy for removing the bias in the graphical analysis method. J. Cereb. Blood Flow Metab. 2001, 21:307-320.
32. 11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 2004, 52:283-291.
33. Millet P., Graf C., Buck A., Walder B., Westera G., Broggini C., Arigoni M., Slosman D., Bouras C., Ibáñez V. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors. J. Cereb. Blood Flow Metab. 2000, 20:1587-1603.
34. Millet P., Ibáñez V., Delforge J., Pappata S., Guimón J. Wavelet analysis of dynamic PET data: application to the parametric imaging of benzodiazepine receptor concentration. Neuroimage 2000, 11:458-472.
35. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 1984, 15:217-227.
36. Mizrahi R., Rusjan P.M., Kennedy J., Pollock B., Mulsant B., Suridjan I., De Luca V., Wilson A.A., Houle S. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J. Cereb. Blood Flow Metab. 2012, 32:968-972.
37. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J. Cereb. Blood Flow Metab. 1991, 11:314-322.
38. Oh U., Fujita M., Ikonomidou V.N., Evangelou I.E., Matsuura E., Harberts E., Ohayon J., Pike V.W., Zhang Y., Zoghbi S.S., Innis R.B., Jacobson S. Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis. J. Neuroimmune Pharmacol. 2011, 6:354-361.
39. Owen D.R., Gunn R.N., Rabiner E.A., Bennacef I., Fujita M., Kreisl W.C., Innis R.B., Pike V.W., Reynolds R., Matthews P.M., Parker C.A. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J. Nucl. Med. 2011, 52:24-32.
40. Owen D.R., Yeo A.J., Gunn R.N., Song K., Wadsworth G., Lewis A., Rhodes C., Pulford D.J., Bennacef I., Parker C.A., StJean P.L., Cardon L.R., Mooser V.E., Matthews P.M., Rabiner E.A., Rubio J.P. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab. 2012, 32:1-5.
41. 11C]PK11195. Neurology 2000, 55:1052-1054.
42. Rao R.V.L., Dogan A., Bowen K.K., Dempsey R.J. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp. Neurol. 2000, 161:102-114.
43. Schoemaker H., Boles R.G., Horst W.D., Yamamura H.I. Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J. Pharmacol. Exp. Ther. 1983, 225:61-69.
44. 18F-FEDAA1106. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:416-423.
45. Slifstein M., Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J. Nucl. Med. 2000, 41:2083-2088.
46. Stephenson D.T., Schober D.A., Smalstig E.B., Mincy R.E., Gehlert D.R., Clemens J.A. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 1995, 15:5263-5274.
47. 11C]DAA1106. Int. J. Neuropsychopharmacol. 2010, 13:943-950.
48. Turkheimer F.E., Brett M., Visvikis D., Cunningham V.J. Multiresolution analysis of emission tomography images in the wavelet domain. J. Cereb. Blood Flow Metab. 1999, 19:1189-1208.
49. Turkheimer F.E., Banati R.B., Visvikis D., Aston J.A., Gunn R.N., Cunningham V.J. Modeling dynamic PET-SPECT studies in the wavelet domain. J. Cereb. Blood Flow Metab. 2000, 20:879-893.
50. Turkheimer F.E., Brett M., Aston J.A., Leff A.P., Sargent P.A., Wise R.J., Grasby P.M., Cunningham V.J. Statistical modeling of positron emission tomography images in wavelet space. J. Cereb. Blood Flow Metab. 2000, 20:1610-1618.
51. 11C]PK11195 in patients. J. Neurol. Sci. 2007, 264:9-17.
52. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., Heiss W.D. The ECAT EXACT HR: performance of a new high resolution positron scanner. J. Comput. Assist. Tomogr. 1994, 18:108-110.
53. 11C]DAA1106. Biol. Psychiatry 2008, 64:835-841.
54. Yokoi T., Iida H., Itoh H., Kanno I. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. J. Nucl. Med. 1993, 34:498-505.
55. 18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). Bioorg. Med. Chem. Lett. 2003, 13:201-204.
56. 18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. J. Med. Chem. 2004, 47:2228-2235.
57. Zhou Y., Ye W., Brasić J.R., Crabb A.H., Hilton J., Wong D.F. A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies. Neuroimage 2009, 44:661-670.